<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Falk A</submitter><funding>Medical Research Council</funding><funding>European Commission FP7</funding><funding>The Brain Tumour Charity</funding><funding>Wellcome Trust</funding><pagination>e29597</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3260177</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(1)</volume><pubmed_abstract>Human embryonic stem cells (hESC) and induced pluripotent stem cells (iPSC) provide new prospects for studying human neurodevelopment and modeling neurological disease. In particular, iPSC-derived neural cells permit a direct comparison of disease-relevant molecular pathways in neurons and glia derived from patients and healthy individuals. A prerequisite for such comparative studies are robust protocols that efficiently yield standardized populations of neural cell types. Here we show that long-term self-renewing neuroepithelial-like stem cells (lt-NES cells) derived from 3 hESC and 6 iPSC lines in two independent laboratories exhibit consistent characteristics including i) continuous expandability in the presence of FGF2 and EGF; ii) stable neuronal and glial differentiation competence; </pubmed_abstract><journal>PloS one</journal><pubmed_title>Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons.</pubmed_title><pmcid>PMC3260177</pmcid><funding_grant_id>8/105</funding_grant_id><funding_grant_id>G1001028</funding_grant_id><funding_grant_id>MC_PC_12009</funding_grant_id><funding_grant_id>G0800784B</funding_grant_id><funding_grant_id>FP7_222943</funding_grant_id><funding_grant_id>G0800784</funding_grant_id><funding_grant_id>G1100526</funding_grant_id><funding_grant_id>079249</funding_grant_id><pubmed_authors>Ladewig J</pubmed_authors><pubmed_authors>Takashima Y</pubmed_authors><pubmed_authors>Falk A</pubmed_authors><pubmed_authors>Kesavan J</pubmed_authors><pubmed_authors>Smith A</pubmed_authors><pubmed_authors>Wiskow O</pubmed_authors><pubmed_authors>Brustle O</pubmed_authors><pubmed_authors>Trotter M</pubmed_authors><pubmed_authors>Pollard S</pubmed_authors><pubmed_authors>Koch P</pubmed_authors><pubmed_authors>Alexander M</pubmed_authors><pubmed_authors>Tailor J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Capture of neuroepithelial-like stem cells from pluripotent stem cells provides a versatile system for in vitro production of human neurons.</name><description>Human embryonic stem cells (hESC) and induced pluripotent stem cells (iPSC) provide new prospects for studying human neurodevelopment and modeling neurological disease. In particular, iPSC-derived neural cells permit a direct comparison of disease-relevant molecular pathways in neurons and glia derived from patients and healthy individuals. A prerequisite for such comparative studies are robust protocols that efficiently yield standardized populations of neural cell types. Here we show that long-term self-renewing neuroepithelial-like stem cells (lt-NES cells) derived from 3 hESC and 6 iPSC lines in two independent laboratories exhibit consistent characteristics including i) continuous expandability in the presence of FGF2 and EGF; ii) stable neuronal and glial differentiation competence; </description><dates><release>2012-01-01T00:00:00Z</release><publication>2012</publication><modification>2025-04-26T16:48:37.537Z</modification><creation>2019-03-26T23:08:25Z</creation></dates><accession>S-EPMC3260177</accession><cross_references><pubmed>22272239</pubmed><doi>10.1371/journal.pone.0029597</doi></cross_references></HashMap>